Ultra Short Acting Insulin Market Insights, Global Outlook and Forecast 2022-2028
Ultra Short Acting Insulin Market Insights, Global Outlook and Forecast 2022-2028
Get latest Market Research Reports on Ultra Short Acting Insulin. Industry analysis and Market Report on Ultra Short Acting Insulin is a syndicated market report, published as Global Ultra Short Acting Insulin Market Research Report . It is complete Research Study and Industry Analysis of Ultra Short Acting Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Ultra Short Acting Insulin in global, including the following market information:
Global Ultra Short Acting Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ultra Short Acting Insulin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Ultra Short Acting Insulin companies in 2021 (%)
The global Ultra Short Acting Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Lispro Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ultra Short Acting Insulin include Eli Lilly and Company, Gan & Lee Pharmaceuticals, Novo Nordisk, Wockhardt, Ypsomed, Tonghua Dongbao, Sanofi, United Laboratory and Jiangsu Wanbang, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Ultra Short Acting Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Ultra Short Acting Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Insulin Market Segment Percentages, by Type, 2021 (%)
Insulin Lispro
Insulin Aspart
Insulin Glulisine
Global Ultra Short Acting Insulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Insulin Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Global Ultra Short Acting Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ultra Short Acting Insulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ultra Short Acting Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ultra Short Acting Insulin revenues share in global market, 2021 (%)
Key companies Ultra Short Acting Insulin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Ultra Short Acting Insulin sales share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Eli Lilly and Company
Gan & Lee Pharmaceuticals
Novo Nordisk
Wockhardt
Ypsomed
Tonghua Dongbao
Sanofi
United Laboratory
Jiangsu Wanbang
B. Braun
Becton, Dickinson
Biocon
Biodel
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Ultra Short Acting Insulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ultra Short Acting Insulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ultra Short Acting Insulin Overall Market Size
2.1 Global Ultra Short Acting Insulin Market Size: 2021 VS 2028
2.2 Global Ultra Short Acting Insulin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ultra Short Acting Insulin Sales: 2017-2028
3 Company Landscape
3.1 Top Ultra Short Acting Insulin Players in Global Market
3.2 Top Global Ultra Short Acting Insulin Companies Ranked by Revenue
3.3 Global Ultra Short Acting Insulin Revenue by Companies
3.4 Global Ultra Short Acting Insulin Sales by Companies
3.5 Global Ultra Short Acting Insulin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ultra Short Acting Insulin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ultra Short Acting Insulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ultra Short Acting Insulin Players in Global Market
3.8.1 List of Global Tier 1 Ultra Short Acting Insulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Ultra Short Acting Insulin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ultra Short Acting Insulin Market Size Markets, 2021 & 2028
4.1.2 Insulin Lispro
4.1.3 Insulin Aspart
4.1.4 Insulin Glulisine
4.2 By Type - Global Ultra Short Acting Insulin Revenue & Forecasts
4.2.1 By Type - Global Ultra Short Acting Insulin Revenue, 2017-2022
4.2.2 By Type - Global Ultra Short Acting Insulin Revenue, 2023-2028
4.2.3 By Type - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
4.3 By Type - Global Ultra Short Acting Insulin Sales & Forecasts
4.3.1 By Type - Global Ultra Short Acting Insulin Sales, 2017-2022
4.3.2 By Type - Global Ultra Short Acting Insulin Sales, 2023-2028
4.3.3 By Type - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
4.4 By Type - Global Ultra Short Acting Insulin Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Ultra Short Acting Insulin Market Size, 2021 & 2028
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.1.4 Gestational Diabetes
5.2 By Application - Global Ultra Short Acting Insulin Revenue & Forecasts
5.2.1 By Application - Global Ultra Short Acting Insulin Revenue, 2017-2022
5.2.2 By Application - Global Ultra Short Acting Insulin Revenue, 2023-2028
5.2.3 By Application - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
5.3 By Application - Global Ultra Short Acting Insulin Sales & Forecasts
5.3.1 By Application - Global Ultra Short Acting Insulin Sales, 2017-2022
5.3.2 By Application - Global Ultra Short Acting Insulin Sales, 2023-2028
5.3.3 By Application - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
5.4 By Application - Global Ultra Short Acting Insulin Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Ultra Short Acting Insulin Market Size, 2021 & 2028
6.2 By Region - Global Ultra Short Acting Insulin Revenue & Forecasts
6.2.1 By Region - Global Ultra Short Acting Insulin Revenue, 2017-2022
6.2.2 By Region - Global Ultra Short Acting Insulin Revenue, 2023-2028
6.2.3 By Region - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
6.3 By Region - Global Ultra Short Acting Insulin Sales & Forecasts
6.3.1 By Region - Global Ultra Short Acting Insulin Sales, 2017-2022
6.3.2 By Region - Global Ultra Short Acting Insulin Sales, 2023-2028
6.3.3 By Region - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Ultra Short Acting Insulin Revenue, 2017-2028
6.4.2 By Country - North America Ultra Short Acting Insulin Sales, 2017-2028
6.4.3 US Ultra Short Acting Insulin Market Size, 2017-2028
6.4.4 Canada Ultra Short Acting Insulin Market Size, 2017-2028
6.4.5 Mexico Ultra Short Acting Insulin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Ultra Short Acting Insulin Revenue, 2017-2028
6.5.2 By Country - Europe Ultra Short Acting Insulin Sales, 2017-2028
6.5.3 Germany Ultra Short Acting Insulin Market Size, 2017-2028
6.5.4 France Ultra Short Acting Insulin Market Size, 2017-2028
6.5.5 U.K. Ultra Short Acting Insulin Market Size, 2017-2028
6.5.6 Italy Ultra Short Acting Insulin Market Size, 2017-2028
6.5.7 Russia Ultra Short Acting Insulin Market Size, 2017-2028
6.5.8 Nordic Countries Ultra Short Acting Insulin Market Size, 2017-2028
6.5.9 Benelux Ultra Short Acting Insulin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Ultra Short Acting Insulin Revenue, 2017-2028
6.6.2 By Region - Asia Ultra Short Acting Insulin Sales, 2017-2028
6.6.3 China Ultra Short Acting Insulin Market Size, 2017-2028
6.6.4 Japan Ultra Short Acting Insulin Market Size, 2017-2028
6.6.5 South Korea Ultra Short Acting Insulin Market Size, 2017-2028
6.6.6 Southeast Asia Ultra Short Acting Insulin Market Size, 2017-2028
6.6.7 India Ultra Short Acting Insulin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Ultra Short Acting Insulin Revenue, 2017-2028
6.7.2 By Country - South America Ultra Short Acting Insulin Sales, 2017-2028
6.7.3 Brazil Ultra Short Acting Insulin Market Size, 2017-2028
6.7.4 Argentina Ultra Short Acting Insulin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ultra Short Acting Insulin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Ultra Short Acting Insulin Sales, 2017-2028
6.8.3 Turkey Ultra Short Acting Insulin Market Size, 2017-2028
6.8.4 Israel Ultra Short Acting Insulin Market Size, 2017-2028
6.8.5 Saudi Arabia Ultra Short Acting Insulin Market Size, 2017-2028
6.8.6 UAE Ultra Short Acting Insulin Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Ultra Short Acting Insulin Major Product Offerings
7.1.4 Eli Lilly and Company Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly and Company Key News
7.2 Gan & Lee Pharmaceuticals
7.2.1 Gan & Lee Pharmaceuticals Corporate Summary
7.2.2 Gan & Lee Pharmaceuticals Business Overview
7.2.3 Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Major Product Offerings
7.2.4 Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.2.5 Gan & Lee Pharmaceuticals Key News
7.3 Novo Nordisk
7.3.1 Novo Nordisk Corporate Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Ultra Short Acting Insulin Major Product Offerings
7.3.4 Novo Nordisk Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.3.5 Novo Nordisk Key News
7.4 Wockhardt
7.4.1 Wockhardt Corporate Summary
7.4.2 Wockhardt Business Overview
7.4.3 Wockhardt Ultra Short Acting Insulin Major Product Offerings
7.4.4 Wockhardt Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.4.5 Wockhardt Key News
7.5 Ypsomed
7.5.1 Ypsomed Corporate Summary
7.5.2 Ypsomed Business Overview
7.5.3 Ypsomed Ultra Short Acting Insulin Major Product Offerings
7.5.4 Ypsomed Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.5.5 Ypsomed Key News
7.6 Tonghua Dongbao
7.6.1 Tonghua Dongbao Corporate Summary
7.6.2 Tonghua Dongbao Business Overview
7.6.3 Tonghua Dongbao Ultra Short Acting Insulin Major Product Offerings
7.6.4 Tonghua Dongbao Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.6.5 Tonghua Dongbao Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Ultra Short Acting Insulin Major Product Offerings
7.7.4 Sanofi Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 United Laboratory
7.8.1 United Laboratory Corporate Summary
7.8.2 United Laboratory Business Overview
7.8.3 United Laboratory Ultra Short Acting Insulin Major Product Offerings
7.8.4 United Laboratory Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.8.5 United Laboratory Key News
7.9 Jiangsu Wanbang
7.9.1 Jiangsu Wanbang Corporate Summary
7.9.2 Jiangsu Wanbang Business Overview
7.9.3 Jiangsu Wanbang Ultra Short Acting Insulin Major Product Offerings
7.9.4 Jiangsu Wanbang Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.9.5 Jiangsu Wanbang Key News
7.10 B. Braun
7.10.1 B. Braun Corporate Summary
7.10.2 B. Braun Business Overview
7.10.3 B. Braun Ultra Short Acting Insulin Major Product Offerings
7.10.4 B. Braun Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.10.5 B. Braun Key News
7.11 Becton, Dickinson
7.11.1 Becton, Dickinson Corporate Summary
7.11.2 Becton, Dickinson Ultra Short Acting Insulin Business Overview
7.11.3 Becton, Dickinson Ultra Short Acting Insulin Major Product Offerings
7.11.4 Becton, Dickinson Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.11.5 Becton, Dickinson Key News
7.12 Biocon
7.12.1 Biocon Corporate Summary
7.12.2 Biocon Ultra Short Acting Insulin Business Overview
7.12.3 Biocon Ultra Short Acting Insulin Major Product Offerings
7.12.4 Biocon Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.12.5 Biocon Key News
7.13 Biodel
7.13.1 Biodel Corporate Summary
7.13.2 Biodel Ultra Short Acting Insulin Business Overview
7.13.3 Biodel Ultra Short Acting Insulin Major Product Offerings
7.13.4 Biodel Ultra Short Acting Insulin Sales and Revenue in Global (2017-2022)
7.13.5 Biodel Key News
8 Global Ultra Short Acting Insulin Production Capacity, Analysis
8.1 Global Ultra Short Acting Insulin Production Capacity, 2017-2028
8.2 Ultra Short Acting Insulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Ultra Short Acting Insulin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ultra Short Acting Insulin Supply Chain Analysis
10.1 Ultra Short Acting Insulin Industry Value Chain
10.2 Ultra Short Acting Insulin Upstream Market
10.3 Ultra Short Acting Insulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ultra Short Acting Insulin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Ultra Short Acting Insulin in Global Market
Table 2. Top Ultra Short Acting Insulin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ultra Short Acting Insulin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ultra Short Acting Insulin Revenue Share by Companies, 2017-2022
Table 5. Global Ultra Short Acting Insulin Sales by Companies, (K Units), 2017-2022
Table 6. Global Ultra Short Acting Insulin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ultra Short Acting Insulin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Ultra Short Acting Insulin Product Type
Table 9. List of Global Tier 1 Ultra Short Acting Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ultra Short Acting Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ultra Short Acting Insulin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ultra Short Acting Insulin Sales (K Units), 2017-2022
Table 15. By Type - Global Ultra Short Acting Insulin Sales (K Units), 2023-2028
Table 16. By Application – Global Ultra Short Acting Insulin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ultra Short Acting Insulin Sales (K Units), 2017-2022
Table 20. By Application - Global Ultra Short Acting Insulin Sales (K Units), 2023-2028
Table 21. By Region – Global Ultra Short Acting Insulin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ultra Short Acting Insulin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ultra Short Acting Insulin Sales (K Units), 2017-2022
Table 25. By Region - Global Ultra Short Acting Insulin Sales (K Units), 2023-2028
Table 26. By Country - North America Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ultra Short Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ultra Short Acting Insulin Sales, (K Units), 2017-2022
Table 29. By Country - North America Ultra Short Acting Insulin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ultra Short Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ultra Short Acting Insulin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Ultra Short Acting Insulin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ultra Short Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ultra Short Acting Insulin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Ultra Short Acting Insulin Sales, (K Units), 2023-2028
Table 38. By Country - South America Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ultra Short Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ultra Short Acting Insulin Sales, (K Units), 2017-2022
Table 41. By Country - South America Ultra Short Acting Insulin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ultra Short Acting Insulin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ultra Short Acting Insulin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Ultra Short Acting Insulin Sales, (K Units), 2023-2028
Table 46. Eli Lilly and Company Corporate Summary
Table 47. Eli Lilly and Company Ultra Short Acting Insulin Product Offerings
Table 48. Eli Lilly and Company Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Gan & Lee Pharmaceuticals Corporate Summary
Table 50. Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Product Offerings
Table 51. Gan & Lee Pharmaceuticals Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novo Nordisk Corporate Summary
Table 53. Novo Nordisk Ultra Short Acting Insulin Product Offerings
Table 54. Novo Nordisk Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Wockhardt Corporate Summary
Table 56. Wockhardt Ultra Short Acting Insulin Product Offerings
Table 57. Wockhardt Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Ypsomed Corporate Summary
Table 59. Ypsomed Ultra Short Acting Insulin Product Offerings
Table 60. Ypsomed Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Tonghua Dongbao Corporate Summary
Table 62. Tonghua Dongbao Ultra Short Acting Insulin Product Offerings
Table 63. Tonghua Dongbao Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Ultra Short Acting Insulin Product Offerings
Table 66. Sanofi Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. United Laboratory Corporate Summary
Table 68. United Laboratory Ultra Short Acting Insulin Product Offerings
Table 69. United Laboratory Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Jiangsu Wanbang Corporate Summary
Table 71. Jiangsu Wanbang Ultra Short Acting Insulin Product Offerings
Table 72. Jiangsu Wanbang Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. B. Braun Corporate Summary
Table 74. B. Braun Ultra Short Acting Insulin Product Offerings
Table 75. B. Braun Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Becton, Dickinson Corporate Summary
Table 77. Becton, Dickinson Ultra Short Acting Insulin Product Offerings
Table 78. Becton, Dickinson Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Biocon Corporate Summary
Table 80. Biocon Ultra Short Acting Insulin Product Offerings
Table 81. Biocon Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Biodel Corporate Summary
Table 83. Biodel Ultra Short Acting Insulin Product Offerings
Table 84. Biodel Ultra Short Acting Insulin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Ultra Short Acting Insulin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Ultra Short Acting Insulin Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Ultra Short Acting Insulin Production by Region, 2017-2022 (K Units)
Table 88. Global Ultra Short Acting Insulin Production by Region, 2023-2028 (K Units)
Table 89. Ultra Short Acting Insulin Market Opportunities & Trends in Global Market
Table 90. Ultra Short Acting Insulin Market Drivers in Global Market
Table 91. Ultra Short Acting Insulin Market Restraints in Global Market
Table 92. Ultra Short Acting Insulin Raw Materials
Table 93. Ultra Short Acting Insulin Raw Materials Suppliers in Global Market
Table 94. Typical Ultra Short Acting Insulin Downstream
Table 95. Ultra Short Acting Insulin Downstream Clients in Global Market
Table 96. Ultra Short Acting Insulin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ultra Short Acting Insulin Segment by Type
Figure 2. Ultra Short Acting Insulin Segment by Application
Figure 3. Global Ultra Short Acting Insulin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ultra Short Acting Insulin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ultra Short Acting Insulin Revenue, 2017-2028 (US$, Mn)
Figure 7. Ultra Short Acting Insulin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ultra Short Acting Insulin Revenue in 2021
Figure 9. By Type - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 10. By Type - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ultra Short Acting Insulin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 13. By Application - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ultra Short Acting Insulin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 16. By Region - Global Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 19. US Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 24. Germany Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 25. France Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 33. China Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 37. India Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 40. Brazil Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ultra Short Acting Insulin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ultra Short Acting Insulin Sales Market Share, 2017-2028
Figure 44. Turkey Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ultra Short Acting Insulin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ultra Short Acting Insulin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Ultra Short Acting Insulin by Region, 2021 VS 2028
Figure 50. Ultra Short Acting Insulin Industry Value Chain
Figure 51. Marketing Channels
Research Methodology:
Ultra Short Acting Insulin Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|